DRUG METABOLISM, ALTERED, CES1-RELATED
|
phenotype |
|
Finding
|
1
|
2
|
0.100 |
None |
|
0 |
2
|
|
|
Wolman Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
19
|
35
|
0.040 |
None |
1.000 |
4 |
|
1972 |
1995 |
Cholesterol Ester Storage Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
3
|
5
|
0.020 |
None |
1.000 |
2 |
|
1972 |
1984 |
Acute lymphocytic leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1293
|
222
|
0.060 |
None |
1.000 |
6 |
|
1991 |
2018 |
Childhood Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1096
|
261
|
0.040 |
None |
1.000 |
4 |
|
1991 |
2018 |
Adult Acute Lymphocytic Leukemia
|
disease |
|
Neoplastic Process
|
860
|
154
|
0.040 |
None |
1.000 |
4 |
|
1991 |
2018 |
Ataxia Telangiectasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
384
|
698
|
0.010 |
None |
1.000 |
1 |
|
1994 |
1994 |
Precursor B-cell lymphoblastic leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
478
|
23
|
0.030 |
None |
1.000 |
3 |
|
1998 |
2018 |
Cocaine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
199
|
39
|
0.300 |
None |
1.000 |
2 |
|
2003 |
2003 |
Hypercholesterolemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
489
|
123
|
0.310 |
None |
1.000 |
2 |
|
2003 |
2018 |
Cocaine Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
144
|
3
|
0.300 |
None |
1.000 |
2 |
|
2003 |
2003 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2004 |
Cocaine-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
121
|
|
0.300 |
None |
1.000 |
2 |
|
2003 |
2003 |
Opioid-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
12
|
23
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Opiate Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
12
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Opioid abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
16
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Opiate Addiction
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
81
|
46
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Narcotic Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
7
|
1
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Narcotic Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2016 |
Childhood Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
1740
|
140
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2016 |
Hypertriglyceridemia
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
340
|
169
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2018 |
Colorectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1296
|
609
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.050 |
None |
1.000 |
5 |
|
2005 |
2019 |
Myeloid Leukemia, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1172
|
115
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |